Local delivery of biodegradable microparticles containing colchicine or a colchicine analogue: effects on restenosis and implications for catheter-based drug delivery
I Gradus-Pizlo,
RL Wilensky,
KL March,
N Fineberg,
M Michaels,
GE Sandusky,
and
DR Hathaway
Krannert Institute of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis 46202-4800, USA.
OBJECTIVES. This study sought to evaluate the delivery efficiency, intramural retention and antirestenotic efficacy of soluble colchicine or colchicine analogue delivered into the arterial wall after angioplasty as well as the efficacy of these medications after prolonged local release from biodegradable microparticles. BACKGROUND. Local delivery of pharmacologic agents is a potential treatment for restenosis. However, the delivery efficiency of the technique and the choice of agent to modulate cellular proliferation are unknown. It was hypothesized that restenosis would be unaffected by colchicine or a hydrophobic colchicine analogue with short intramural retention, whereas it would be reduced after prolonged local release. METHODS. Rabbit atherosclerotic femoral arteries underwent angioplasty followed by local delivery. Delivery efficiency and intramural retention of 3H-colchicine were evaluated. The effect of agents in soluble formulation or released from microparticles on angiographic and morphometric restenosis was evaluated at 2 weeks and compared with that in the control groups (angioplasty only and local infusion of carrier solution). RESULTS. Delivery of efficiency was 0.01% and intramural retention < 24 h. Neither soluble colchicine formulation reduced restenosis. Microparticles releasing the colchicine analogue reduced restenosis compared with control and colchicine microparticles but not angioplasty alone (p = 0.002). Delivery outside the artery was observed, and the long-term release of both colchicine resulted in toxicity to the adjacent musculature. CONCLUSIONS. Colchicine or the colchicine analogue did not reduce restenosis, although the long-term local release of the colchicine analogue reduced neointimal proliferation resulting from local delivery. Local delivery of cytotoxic agents with insufficient vascular specificity may be limited by toxicity to adjacent tissues resulting from a larger than expected delivery area and prolonged agent retention.
This article has been cited by other articles:

|
 |

|
 |
 
T. Cyrus, H. Zhang, J. S. Allen, T. A. Williams, G. Hu, S. D. Caruthers, S. A. Wickline, and G. M. Lanza
Intramural Delivery of Rapamycin With {alpha}v{beta}3-Targeted Paramagnetic Nanoparticles Inhibits Stenosis After Balloon Injury
Arterioscler Thromb Vasc Biol,
May 1, 2008;
28(5):
820 - 826.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. S. Do, E. Y. Kao, F. Ganaha, H. Minamiguchi, K. Sugimoto, J. Lee, C. J. Elkins, P. G. Amabile, M. D. Kuo, D. S. Wang, et al.
In-Stent Restenosis Limitation with Stent-based Controlled-Release Nitric Oxide: Initial Results in Rabbits
Radiology,
February 1, 2004;
230(2):
377 - 382.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. F. Meneveau, B. D. Klugherz, B. Chaquor, M. A. Golden, M. M. Jouille, E. Macarek, P. B. Weisz, and R. L. Wilensky
Separate and Combined Effects of Local and Continuous Intravenous Administration of {beta}-Cyclodextrin Tetradecasulfate on Intimal Hyperplasia after Angioplasty in Porcine Coronary Arteries
Journal of Cardiovascular Pharmacology and Therapeutics,
March 1, 2003;
8(1):
53 - 60.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Sasseen, B. D. Gray, D. Gal, R. Lorinc, D. C. Carpenter, B. D. Klugherz, and R. L. Wilensky
Local Delivery of a Hydrophobic Heparin Reduces Neointimal Hyperplasia After Balloon Injury in Rat Carotid but not Pig Coronary Arteries
Journal of Cardiovascular Pharmacology and Therapeutics,
December 1, 2001;
6(4):
377 - 383.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kanamasa, Y. Inoue, N. Otani, N. Naito, H. Morii, A. Ikeda, M. Taniguchi, N. Ishida, T. Hayashi, and K. Ishikawa
tPA via Infusion Catheters Followed by Continuous IV Infusion for 3 Days Prevents Intimal Hyperplasia After Balloon Injury
Angiology,
December 1, 2001;
52(12):
819 - 825.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Fishbein, M. Chorny, S. Banai, A. Levitzki, H. D. Danenberg, J. Gao, X. Chen, E. Moerman, I. Gati, V. Goldwasser, et al.
Formulation and Delivery Mode Affect Disposition and Activity of Tyrphostin-Loaded Nanoparticles in the Rat Carotid Model
Arterioscler Thromb Vasc Biol,
September 1, 2001;
21(9):
1434 - 1439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N Meneveau, F Schiele, G Grollier, B Farah, J.M Lablanche, K Khalife, J Machecourt, N Danchin, J.E Wolf, M Simpson, et al.
Local delivery of nadroparin for the prevention of neointimal hyperplasia following stent implantation: results of the IMPRESS Trial. A multicentre, randomized, clinical, angiographic and intravascular ultrasound study
Eur. Heart J.,
November 1, 2000;
21(21):
1767 - 1775.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
F. D. Kolodgie, A. Farb, and R. Virmani
Local Delivery of Ceramide for Restenosis : Is There a Future for Lipid Therapy?
Circ. Res.,
August 18, 2000;
87(4):
264 - 267.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. G. Lehmann, J. J. Popma, J. A. Werner, A. J. Lansky, and R. L. Wilensky
Vascular remodeling and the local delivery of cytochalasin B after coronary angioplasty in humans
J. Am. Coll. Cardiol.,
March 1, 2000;
35(3):
583 - 591.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Wilensky, K. Mehdi, K. M. Sowinski, Sang Hong Baek, and K. L. March
Increased Intramural Retention After Local Delivery of Molecules with Increased Binding Properties: Implications for Regional Delivery of Pharmacologic Agents
Journal of Cardiovascular Pharmacology and Therapeutics,
January 1, 1999;
4(2):
103 - 112.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Klugherz, N. Meneveau, W. Chen, F. Wade-Whittaker, G. Papandreou, R. Levy, and R. L. Wilensky
Sustained Intramural Retention and Regional Redistribution Following Local Vascular Delivery of Polylactic-Coglycolic Acid and Liposomal Nanoparticulate Formulations Containing Probucol
Journal of Cardiovascular Pharmacology and Therapeutics,
January 1, 1999;
4(3):
167 - 174.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Baek and K. L. March
Gene Therapy for Restenosis : Getting Nearer the Heart of the Matter
Circ. Res.,
February 23, 1998;
82(3):
295 - 305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Baldwin, L. M. Wilson, I. Gradus-Pizlo, R. Wilensky, and K. March
Effect of Atherosclerosis on Transmural Convection and Arterial Ultrastructure : Implications for Local Intravascular Drug Delivery
Arterioscler Thromb Vasc Biol,
December 1, 1997;
17(12):
3365 - 3375.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. I. Axel, W. Kunert, C. Goggelmann, M. Oberhoff, C. Herdeg, A. Kuttner, D. H. Wild, B. R. Brehm, R. Riessen, G. Koveker, et al.
Paclitaxel Inhibits Arterial Smooth Muscle Cell Proliferation and Migration In Vitro and In Vivo Using Local Drug Delivery
Circulation,
July 15, 1997;
96(2):
636 - 645.
[Abstract]
[Full Text]
|
 |
|
|